Vimarsana
Biggest News Aggregation in the World

Page 2 - Antonio Risitano News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antonio Risitano. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antonio Risitano Today - Breaking & Trending Today

Trial data released for potentially "practice-changing" PNH medicine - Vimarsana News

Trial data released for potentially "practice-changing" PNH medicine

Published: April 26, 2023

Iptacopan achieved "improvement of anaemia never seen before with anti-C5s” in PNH, showed Novartis data presented at 2023 EBMT.

Source: europeanpharmaceuticalreview.com
Related Topics:
France GeneralDavid SoergelAntonio RisitanoGiuseppe MoscatiInterest GroupMeeting Of The European Society For BloodReference CenterMetabolism Development Unit At NovartisGreater Paris University HospitalEuropean SocietyMarrow TransplantationPeffault De LatourSaint Louis HospitalGreater Paris UniversityHematopoietic Transplant UnitAplastic AnemiaParoxysmal Nocturnal HemoglobinuriaGlobal HeadMetabolism Development Unit
Iptacopan Meets Primary End Point of APPOINT-PNH Trial in Paroxysmal Nocturnal Hemoglobinuria - Vimarsana News

Iptacopan Meets Primary End Point of APPOINT-PNH Trial in Paroxysmal Nocturnal Hemoglobinuria

Published: April 26, 2023

Iptacopan elicited improved hemoglobin levels measuring at least 2 g/dL higher vs baseline, leading to transfusion independence after 24 weeks in approximately 92.2% of patients with complement inhibitor–naïve paroxysmal nocturnal hemoglobinuria.

Source: onclive.com
Related Topics:
France GeneralAntonio RisitanoGiuseppe MoscatiDavid SoergelMetabolism Development UnitInterest GroupReference CenterGreater Paris University HospitalFunctional AssessmentChronic Illness TherapyHematopoietic Transplant UnitAplastic AnemiaParoxysmal Nocturnal HemoglobinuriaPeffault De LatourSaint Louis HospitalAppoint Pnh Trial